(MedPage Today) — In the decade since palbociclib (Ibrance) received FDA approval, results from multiple clinical trials have provided a strong evidence base to make cyclin-dependent kinase (CDK)4/6 inhibitors, in combination with endocrine therapy…
‘The Devil Wears Prada 2’ review: A sequel just as good, that’s all
Fans of the original will enjoy seeing Anne Hathaway, Meryl Streep, Emily Blunt, and Stanley Tucci sliding back into their...






